NEPHROS INC (NEPH)

US6406714005 - Common Stock

2.19  +0.05 (+2.34%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
10.22M
19.39%		9.98M
-2.35%		14.238M
42.67%		17.035M
19.64%
EBITDA
YoY % growth
-3M
26.29%		-3.99M
-33.00%		-1.379M
65.44%		N/AN/A
EBIT
YoY % growth
-3.25M
24.07%		-4.34M
-33.54%		-1.593M
63.29%		-734.91K
53.87%
Operating Margin
-31.80%-43.49%-11.19%-4.31%
EPS
YoY % growth
-0.46
11.54%		-0.73
-58.70%		-0.15
79.45%		-0.07
55.80%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.04
-36.00%
Revenue
Q2Q % growth		3.809M
2.95%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-453.9K
-46.42%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.06
40.00%		-0.03-0.03-135.29%
Q3 2023
Q2Q % growth		 -0.02
93.55%		-0.070.0569.83%
Q2 2023
Q2Q % growth		 -0.04
66.67%		-0.060.0228.70%
Q1 2023
Q2Q % growth		 -0.03
85.00%		-0.02-0.01-47.06%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 14.238M
456.17%		3.89M10.348M266.02%
Q3 2023
Q2Q % growth		 3.74M
55.19%		3.422M318K9.29%
Q2 2023
Q2Q % growth		 3.55M
24.56%		3.169M381K12.02%
Q1 2023
Q2Q % growth		 3.7M
71.30%		3.753M-53K-1.41%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -33.33% -62.5% -62.5%
Revenue0% -3.89% -2.07% -2.07%